Segmental obstruction of the hepatic inferior vena cava treated by transluminal angioplasty
Related Experiment Videos
Insights
Percutaneous transluminal angioplasty effectively treated hepatic inferior vena cava obstruction in Budd-Chiari syndrome patients. This minimally invasive procedure achieved long-term vessel patency without significant complications.
Area of Science:
- Interventional Cardiology
- Vascular Surgery
- Hepatology
Background:
- Budd-Chiari syndrome often involves hepatic inferior vena cava obstruction.
- Segmental obstruction presents a unique therapeutic challenge.
- Traditional treatments may have limitations.
Observation:
- Five patients with Budd-Chiari syndrome and segmental hepatic inferior vena cava obstruction were studied.
- Percutaneous transluminal angioplasty (PTA) was employed as the treatment modality.
- Grüntzig balloon catheters were utilized for vessel dilatation.
Findings:
- Simultaneous use of three to four balloons achieved sufficient dilatation.
- All five patients demonstrated successful treatment outcomes.
- Long-term patency of the hepatic inferior vena cava was achieved in all cases.
- No serious complications were reported during or after the procedure.
Implications:
- PTA is a safe and effective treatment for segmental hepatic inferior vena cava obstruction.
- The technique shows promise for treating similar venous obstructions elsewhere.
- This minimally invasive approach offers a viable alternative for Budd-Chiari syndrome management.
Abstract:
Five patients with segmental obstruction of the hepatic inferior vena cava associated with Budd-Chiari syndrome were successfully treated by percutaneous transluminal angioplasty using Grüntzig balloon catheters. Three or four balloons were used simultaneously to achieve sufficient dilatation. Long-term patency was obtained in all 5 cases without serious complications. This procedure may be applicable to other portions of the venous system as well.